skip navigation

Skip Nav

HIV/AIDS News

HIV/AIDS News Search Results

8 news items were found. [Date: May 1, 2002 - May 31, 2002]

RadDatePicker
From date
RadDatePicker
To date

A New Day for HIV/AIDS Prevention

Date: May 18, 2002
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/607/a-new-day-for-hiv-aids-prevention/

NIAID Teams with Wyeth on HIV/AIDS Vaccine

Date: May 17, 2002
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/606/niaid-teams-with-wyeth-on-hiv-aids-vaccine/

HIV Vaccine Research is "Best Hope" for Controlling AIDS Pandemic

Date: May 16, 2002
http://www.nih.gov/news/pr/may2002/niaid-16.htm

Black and Hispanic HIV Patients Are Less Likely to Get Experimental Medications

Date: May 1, 2002
Source: Agency for Healthcare Research and Quality (AHRQ)
http://aidsinfo.nih.gov/news/610/black-and-hispanic-hiv-patients-are-less-likely-to-get-experimental-medications/

Challenges in Designing HIV Vaccines

Date: May 1, 2002
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/127/challenges-in-designing-hiv-vaccines/

Clinical Research on HIV Vaccines

Date: May 1, 2002
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/129/clinical-research-on-hiv-vaccines/

HIV Selectively Suppresses Anti-HIV Defense Cells

Date: May 1, 2002
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/604/hiv-selectively-suppresses-anti-hiv-defense-cells/

Resources for HIV Vaccine Research and Development

Date: May 1, 2002
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/529/resources-for-hiv-vaccine-research-and-development/